Medical Weight Loss for Dubuque, Iowa Residents
Dubuque, Iowa residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Dubuque through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Dubuque Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Dubuque, Iowa residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
From our Costa Mesa, California practice, we provide Dubuque with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.
Patients across Dubuque and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Iowa. We care for patients throughout downtown Dubuque and the greater area on the Mississippi River in eastern Iowa. Every prescription for Dubuque is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
Our telehealth model serves Dubuque and communities across Iowa with the same flat pricing and the same supervising physician. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Dubuque patients.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Dubuque patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Dubuque
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Dubuque address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Dubuque
Does New Hope Weight Loss treat patients in Dubuque?
Yes. Although the clinic is in Costa Mesa, California, we treat Dubuque, Iowa residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Dubuque?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Dubuque address in cold-pack packaging.
What do Dubuque patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Dubuque do you serve?
We serve patients from across Dubuque by telehealth, including downtown Dubuque and the greater area on the Mississippi River in eastern Iowa.
Who qualifies for the program in Dubuque?
Eligibility for Dubuque patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Dubuque, Iowa by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.